AstraZeneca Inks $51.4M Settlement In Pay-For-Delay Case
By Hailey Konnath · May 29, 2025, 11:53 PM EDT
AstraZeneca Pharmaceuticals LP and Handa Pharmaceuticals LLC have agreed to shell out a combined $51.4 million to put to rest allegations AstraZeneca paid off generic-drug makers, including Handa, to protect its brand...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login